申请人:Santen Pharmaceutical Co., Ltd
公开号:EP2119703A1
公开(公告)日:2009-11-18
Disclosed is a compound represented by the general formula (1) or a salt thereof. The compound or a salt thereof has an inhibitory activity on IKKβ and is therefore useful as preventive and/or therapeutic agent for a disease associated with IKKβ. In the formula, R1 represents a hydrogen atom, a lower alkyl group, an aryl group, a hydroxy group, or the like; R2 represents a halogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group, or the like; and m represents 0, 1, 2, or the like.
本发明公开了通式(1)所代表的化合物或其盐。该化合物或其盐对 IKKβ 具有抑制活性,因此可用作与 IKKβ 相关疾病的预防和/或治疗剂。式中,R1 代表氢原子、低级烷基、芳基、羟基或类似基团;R2 代表卤素原子、低级烷基、低级烯基、低级炔基或类似基团;m 代表 0、1、2 或类似基团。